ORIENT BIO Inc. (KRX:002630)

South Korea flag South Korea · Delayed Price · Currency is KRW
681.00
-19.00 (-2.71%)
At close: Jul 25, 2025, 3:30 PM KST
-2.71%
Market Cap80.74B
Revenue (ttm)59.09B
Net Income (ttm)-6.85B
Shares Out118.57M
EPS (ttm)-57.81
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,219,942
Average Volume3,700,815
Open709.00
Previous Close700.00
Day's Range678.00 - 709.00
52-Week Range408.00 - 2,560.00
Beta0.66
RSI24.56
Earnings Daten/a

About ORIENT BIO

ORIENT BIO Inc. operates in the bio-industry in South Korea. It produces laboratory animals; and offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1959
Employees 125
Stock Exchange Korea Stock Exchange
Ticker Symbol 002630
Full Company Profile

Financial Performance

In 2020, ORIENT BIO's revenue was 52.02 billion, an increase of 39.79% compared to the previous year's 37.21 billion. Losses were -15.63 billion, 30.3% more than in 2019.

Financial Statements

News

There is no news available yet.